{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T21:37:37Z","timestamp":1783287457810,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,30]]},"DOI":"10.7759\/cureus.44419","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T06:30:42Z","timestamp":1693463442000},"source":"Crossref","is-referenced-by-count":2,"title":["Mildly Low Serum Sodium Levels in Chronic Liver Disease: At Risk for Sarcopenia and Portal Hypertension"],"prefix":"10.7759","author":[{"given":"Atsushi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)32178-7","article-title":"Pathophysiology, diagnosis and treatment of ascites in cirrhosis","volume":"1","author":"Arroyo V","year":"2002","unstructured":"Arroyo V. Pathophysiology, diagnosis and treatment of ascites in cirrhosis. Ann Hepatol. 2002, 1:72-9. 10.1016\/S1665-2681(19)32178-7","journal-title":"Ann Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22418","article-title":"Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management","volume":"48","author":"Gin\u00e8s P","year":"2008","unstructured":"Gin\u00e8s P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008, 48:1002-10. 10.1002\/hep.22418","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim WR","year":"2008","unstructured":"Kim WR, Biggins SW, Kremers WK, et al.. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008, 359:1018-26. 10.1056\/NEJMoa0801209","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000786","article-title":"Hyponatremia in cirrhosis: an update","volume":"115","author":"Alukal JJ","year":"2020","unstructured":"Alukal JJ, John S, Thuluvath PJ. Hyponatremia in cirrhosis: an update. Am J Gastroenterol. 2020, 115:1775-85. 10.14309\/ajg.0000000000000786","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13750","article-title":"To salt or not to salt?-That is the question in cirrhosis","volume":"38","author":"Haberl J","year":"2018","unstructured":"Haberl J, Zollner G, Fickert P, Stadlbauer V. To salt or not to salt?-That is the question in cirrhosis. Liver Int. 2018, 38:1148-59. 10.1111\/liv.13750","journal-title":"Liver Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S138535","article-title":"Hyponatremia in the elderly: challenges and solutions","volume":"12","author":"Filippatos TD","year":"2017","unstructured":"Filippatos TD, Makri A, Elisaf MS, Liamis G. Hyponatremia in the elderly: challenges and solutions. Clin Interv Aging. 2017, 12:1957-65. 10.2147\/CIA.S138535","journal-title":"Clin Interv Aging"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030978","article-title":"Morbidity associated with chronic hyponatremia","volume":"12","author":"Decaux G","year":"2023","unstructured":"Decaux G. Morbidity associated with chronic hyponatremia. J Clin Med. 2023, 12:10.3390\/jcm12030978","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.09.026","article-title":"Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits","volume":"119","author":"Renneboog B","year":"2006","unstructured":"Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006, 119:71.e1-8. 10.1016\/j.amjmed.2005.09.026","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw029","article-title":"Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly","volume":"31","author":"Ayus JC","year":"2016","unstructured":"Ayus JC, Fuentes NA, Negri AL, et al.. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly. Nephrol Dial Transplant. 2016, 31:1662-9. 10.1093\/ndt\/gfw029","journal-title":"Nephrol Dial Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-011-9347-9","article-title":"Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats","volume":"35","author":"Barsony J","year":"2013","unstructured":"Barsony J, Manigrasso MB, Xu Q, Tam H, Verbalis JG. Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats. Age (Dordr). 2013, 35:271-88. 10.1007\/s11357-011-9347-9","journal-title":"Age (Dordr)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-020-01955-4","article-title":"Mild hyponatremia is associated with low skeletal muscle mass, physical function impairment, and depressive mood in the elderly","volume":"21","author":"Fujisawa C","year":"2021","unstructured":"Fujisawa C, Umegaki H, Sugimoto T, et al.. Mild hyponatremia is associated with low skeletal muscle mass, physical function impairment, and depressive mood in the elderly. BMC Geriatr. 2021, 21:15. 10.1186\/s12877-020-01955-4","journal-title":"BMC Geriatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01788-x","article-title":"Evidence-based clinical practice guidelines for Liver Cirrhosis 2020","volume":"56","author":"Yoshiji H","year":"2021","unstructured":"Yoshiji H, Nagoshi S, Akahane T, et al.. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol. 2021, 56:593-619. 10.1007\/s00535-021-01788-x","journal-title":"J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai JC","year":"2021","unstructured":"Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021, 74:1611-44. 10.1002\/hep.32049","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba R","year":"2020","unstructured":"Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis. Gut. 2020, 69:1343-52. 10.1136\/gutjnl-2018-317593","journal-title":"Gut"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0012-0","article-title":"When and how to use magnetic resonance elastography for patients with liver disease in clinical practice","volume":"113","author":"Venkatesh SK","year":"2018","unstructured":"Venkatesh SK, Talwalkar JA. When and how to use magnetic resonance elastography for patients with liver disease in clinical practice. Am J Gastroenterol. 2018, 113:923-6. 10.1038\/s41395-018-0012-0","journal-title":"Am J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16745","article-title":"Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality","volume":"55","author":"Higuchi M","year":"2022","unstructured":"Higuchi M, Tamaki N, Kurosaki M, et al.. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality. Aliment Pharmacol Ther. 2022, 55:292-301. 10.1111\/apt.16745","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32151","article-title":"Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: a retrospective study","volume":"75","author":"Gidener T","year":"2022","unstructured":"Gidener T, Yin M, Dierkhising RA, Allen AM, Ehman RL, Venkatesh SK. Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: a retrospective study. Hepatology. 2022, 75:379-90. 10.1002\/hep.32151","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29602","article-title":"Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis","volume":"67","author":"Praktiknjo M","year":"2018","unstructured":"Praktiknjo M, Book M, Luetkens J, et al.. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology. 2018, 67:1014-26. 10.1002\/hep.29602","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24676","article-title":"Diagnosis and pathogenesis of sarcopenia in chronic liver disease using liver magnetic resonance imaging","volume":"14","author":"Nakamura A","year":"2022","unstructured":"Nakamura A, Yoshimura T, Sato T, Ichikawa T. Diagnosis and pathogenesis of sarcopenia in chronic liver disease using liver magnetic resonance imaging. Cureus. 2022, 14:e24676. 10.7759\/cureus.24676","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson PJ","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, et al.. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015, 33:550-8. 10.1200\/JCO.2014.57.9151","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000488778","article-title":"Validation of modified ALBI grade for more detailed assessment of hepatic function in hepatocellular carcinoma patients: a multicenter analysis","volume":"8","author":"Hiraoka A","year":"2019","unstructured":"Hiraoka A, Kumada T, Tsuji K, et al.. Validation of modified ALBI grade for more detailed assessment of hepatic function in hepatocellular carcinoma patients: a multicenter analysis. Liver Cancer. 2019, 8:121-9. 10.1159\/000488778","journal-title":"Liver Cancer"},{"key":"ref22","article-title":"A national surveillance study on alcoholic liver disease in Japan (1986-1991) [Article in Japanese]","volume":"91","author":"Takada A","year":"1994","unstructured":"Takada A, Matsuda Y, Takase S, et al.. A national surveillance study on alcoholic liver disease in Japan (1986-1991) [Article in Japanese]. Nihon Shokakibyo Gakkai Zasshi. 1994, 91:887-98.","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography","volume":"150","author":"Imajo K","year":"2016","unstructured":"Imajo K, Kessoku T, Honda Y, et al.. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016, 150:626-637.e7. 10.1053\/j.gastro.2015.11.048","journal-title":"Gastroenterology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero JA","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, et al.. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018, 68:723-50. 10.1002\/hep.29913","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13411","article-title":"Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update","volume":"49","author":"Kokudo N","year":"2019","unstructured":"Kokudo N, Takemura N, Hasegawa K, et al.. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol Res. 2019, 49:1109-13. 10.1111\/hepr.13411","journal-title":"Hepatol Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.06.012","article-title":"Assessment of hepatic fibrosis with magnetic resonance elastography","volume":"5","author":"Yin M","year":"2007","unstructured":"Yin M, Talwalkar JA, Glaser KJ, et al.. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007, 5:1207-1213.e2. 10.1016\/j.cgh.2007.06.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.20831","article-title":"Water-fat separation with IDEAL gradient-echo imaging","volume":"25","author":"Reeder SB","year":"2007","unstructured":"Reeder SB, McKenzie CA, Pineda AR, et al.. Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging. 2007, 25:644-52. 10.1002\/jmri.20831","journal-title":"J Magn Reson Imaging"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.05.059","article-title":"Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants","volume":"17","author":"Hsu C","year":"2019","unstructured":"Hsu C, Caussy C, Imajo K, et al.. Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants. Clin Gastroenterol Hepatol. 2019, 17:630-637.e8. 10.1016\/j.cgh.2018.05.059","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.25868","article-title":"Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging","volume":"47","author":"Morisaka H","year":"2018","unstructured":"Morisaka H, Motosugi U, Ichikawa S, et al.. Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging. J Magn Reson Imaging. 2018, 47:1268-75. 10.1002\/jmri.25868","journal-title":"J Magn Reson Imaging"},{"key":"ref30","article-title":"CONUT: a tool for controlling nutritional status. First validation in a hospital population","volume":"20","author":"Ignacio de Ul\u00edbarri J","year":"2005","unstructured":"Ignacio de Ul\u00edbarri J, Gonz\u00e1lez-Madro\u00f1o A, de Villar NG, et al.. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005, 20:38-45.","journal-title":"Nutr Hosp"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22242","article-title":"Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma","volume":"107","author":"Lu SN","year":"2006","unstructured":"Lu SN, Wang JH, Liu SL, et al.. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer. 2006, 107:2212-22. 10.1002\/cncr.22242","journal-title":"Cancer"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1148\/rg.220181","article-title":"Liver fibrosis, fat, and iron evaluation with MRI and fibrosis and fat evaluation with US: a practical guide for radiologists","volume":"43","author":"Guglielmo FF","year":"2023","unstructured":"Guglielmo FF, Barr RG, Yokoo T, et al.. Liver fibrosis, fat, and iron evaluation with MRI and fibrosis and fat evaluation with US: a practical guide for radiologists. Radiographics. 2023, 43:e220181. 10.1148\/rg.220181","journal-title":"Radiographics"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221093869","article-title":"Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease","volume":"15","author":"Ajmera V","year":"2022","unstructured":"Ajmera V, Nguyen K, Tamaki N, Sharpton S, Bettencourt R, Loomba R. Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2022, 15:17562848221093869. 10.1177\/17562848221093869","journal-title":"Therap Adv Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al.. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023, 77:1797-835. 10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13927","article-title":"Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease","volume":"33","author":"Abe K","year":"2018","unstructured":"Abe K, Takahashi A, Imaizumi H, et al.. Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease. J Gastroenterol Hepatol. 2018, 33:733-40. 10.1111\/jgh.13927","journal-title":"J Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.016","article-title":"Role of magnetic resonance elastography in compensated and decompensated liver disease","volume":"60","author":"Asrani SK","year":"2014","unstructured":"Asrani SK, Talwalkar JA, Kamath PS, et al.. Role of magnetic resonance elastography in compensated and decompensated liver disease. J Hepatol. 2014, 60:934-9. 10.1016\/j.jhep.2013.12.016","journal-title":"J Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13263","article-title":"Performance of magnetic resonance elastography in primary sclerosing cholangitis","volume":"31","author":"Eaton JE","year":"2016","unstructured":"Eaton JE, Dzyubak B, Venkatesh SK, et al.. Performance of magnetic resonance elastography in primary sclerosing cholangitis. J Gastroenterol Hepatol. 2016, 31:1184-90. 10.1111\/jgh.13263","journal-title":"J Gastroenterol Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14593","article-title":"MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: a multicenter study","volume":"40","author":"Han MA","year":"2020","unstructured":"Han MA, Vipani A, Noureddin N, et al.. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: a multicenter study. Liver Int. 2020, 40:2242-51. 10.1111\/liv.14593","journal-title":"Liver Int"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.21.2564","article-title":"Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage","volume":"161","author":"Zaman A","year":"2001","unstructured":"Zaman A, Becker T, Lapidus J, Benner K. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med. 2001, 161:2564-70. 10.1001\/archinte.161.21.2564","journal-title":"Arch Intern Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis R","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022, 76:959-74. 10.1016\/j.jhep.2021.12.022","journal-title":"J Hepatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100513","article-title":"Risk of further decompensation\/mortality in patients with cirrhosis and ascites as the first single decompensation event","volume":"4","author":"Balcar L","year":"2022","unstructured":"Balcar L, Tonon M, Semmler G, et al.. Risk of further decompensation\/mortality in patients with cirrhosis and ascites as the first single decompensation event. JHEP Rep. 2022, 4:100513. 10.1016\/j.jhepr.2022.100513","journal-title":"JHEP Rep"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.03.065","article-title":"Outcomes and mortality of Grade 1 ascites and recurrent ascites in patients with cirrhosis","volume":"19","author":"Tonon M","year":"2021","unstructured":"Tonon M, Piano S, Gambino CG, et al.. Outcomes and mortality of Grade 1 ascites and recurrent ascites in patients with cirrhosis. Clin Gastroenterol Hepatol. 2021, 19:358-366.e8. 10.1016\/j.cgh.2020.03.065","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12869","article-title":"Sarcopenia as a prognostic indicator of liver cirrhosis","volume":"13","author":"Kim SE","year":"2022","unstructured":"Kim SE, Kim DJ. Sarcopenia as a prognostic indicator of liver cirrhosis. J Cachexia Sarcopenia Muscle. 2022, 13:8-10. 10.1002\/jcsm.12869","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101694","article-title":"Low serum alkaline phosphatase levels in patients with chronic liver diseases: possible contributions to disease pathogenesis","volume":"45","author":"Iluz-Freundlich D","year":"2021","unstructured":"Iluz-Freundlich D, Grubert Van Iderstine M, Uhanova J, Zhang M, Knowles C, Minuk GY. Low serum alkaline phosphatase levels in patients with chronic liver diseases: possible contributions to disease pathogenesis. Clin Res Hepatol Gastroenterol. 2021, 45:101694. 10.1016\/j.clinre.2021.101694","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.03.029","article-title":"Sarcopenia as a potential cause of chronic hyponatremia in the elderly","volume":"127","author":"Bertini V","year":"2019","unstructured":"Bertini V, Nicoletti C, Beker BM, Musso CG. Sarcopenia as a potential cause of chronic hyponatremia in the elderly. Med Hypotheses. 2019, 127:46-8. 10.1016\/j.mehy.2019.03.029","journal-title":"Med Hypotheses"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3945\/an.113.005215","article-title":"Sodium","volume":"5","author":"Strazzullo P","year":"2014","unstructured":"Strazzullo P, Leclercq C. Sodium. Adv Nutr. 2014, 5:188-90. 10.3945\/an.113.005215","journal-title":"Adv Nutr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12412","article-title":"Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis","volume":"45","author":"Umemura T","year":"2015","unstructured":"Umemura T, Shibata S, Sekiguchi T, et al.. Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis. Hepatol Res. 2015, 45:739-44. 10.1111\/hepr.12412","journal-title":"Hepatol Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2012.6.3.355","article-title":"Effect of a diet with unrestricted sodium on ascites in patients with hepatic cirrhosis","volume":"6","author":"Gu XB","year":"2012","unstructured":"Gu XB, Yang XJ, Zhu HY, Xu BY. Effect of a diet with unrestricted sodium on ascites in patients with hepatic cirrhosis. Gut Liver. 2012, 6:355-61. 10.5009\/gnl.2012.6.3.355","journal-title":"Gut Liver"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21412","article-title":"Hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli P","year":"2006","unstructured":"Angeli P, Wong F, Watson H, Gin\u00e8s P. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology. 2006, 44:1535-42. 10.1002\/hep.21412","journal-title":"Hepatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/174521-mildly-low-serum-sodium-levels-in-chronic-liver-disease-at-risk-for-sarcopenia-and-portal-hypertension","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:59Z","timestamp":1707508679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/174521-mildly-low-serum-sodium-levels-in-chronic-liver-disease-at-risk-for-sarcopenia-and-portal-hypertension"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.44419","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,30]]}}}